LBBW Aktienanleihe OMV 28.03.2025/ DE000LB3NZZ4 /
2024-10-11 10:20:03 AM | Chg.+0.01 | Bid10:00:22 PM | Ask10:00:22 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.11EUR | +0.01% | - Bid Size: - |
- Ask Size: - |
OMV AG | 26.95 EUR | 2025-03-28 | Call |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center